This cross-sectional study examines utilization trends for filgrastim and infliximab products and their biosimilars to understand whether biosimilars are associated with reduced spending in Medicare Part D.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8902649 | PMC |
| http://dx.doi.org/10.1001/jamanetworkopen.2022.1117 | DOI Listing |
Publication Analysis
Top Keywords
filgrastim infliximab
8
utilization filgrastim
4
infliximab biosimilar
4
biosimilar products
4
products medicare
4
medicare 2015-2019
4
2015-2019 cross-sectional
4
cross-sectional study
4
study examines
4
examines utilization
4
Similar Publications
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!